US Stock MarketDetailed Quotes

Avalo Therapeutics (AVTX)

Watchlist
  • 14.420
  • +1.070+8.01%
Close Apr 16 16:00 ET
  • 14.840
  • +0.420+2.91%
Post 20:01 ET
385.22MMarket Cap-2.47P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Avalo Therapeutics (AVTX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.90%-51.46M
5.30%-14.25M
-41.97%-16.37M
30.05%-11.39M
-52.48%-9.46M
-59.90%-49.06M
-443.89%-15.04M
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
Net income from continuing operations
-122.78%-78.26M
61.18%-13.72M
-232.94%-30.63M
-121.09%-20.77M
89.16%-13.15M
-11.37%-35.13M
-332.65%-35.34M
540.65%23.04M
1,301.79%98.46M
-1,118.38%-121.29M
Operating gains losses
124.16%9.52M
-122.31%-5.16M
135.88%12.53M
109.12%2.53M
-416.67%-380K
-5,572.92%-39.41M
3,755.00%23.13M
-34,825.00%-34.93M
-69,425.00%-27.73M
-33.33%120K
Depreciation and amortization
103.55%344K
-76.47%16K
73.53%59K
306.06%134K
297.06%135K
6.96%169K
58.14%68K
-17.07%34K
-19.51%33K
3.03%34K
Deferred tax
44.74%165K
14.91%131K
171.43%10K
7,400.00%525K
-7,257.14%-501K
714.29%114K
1,366.67%114K
-275.00%-14K
0.00%7K
-12.50%7K
Other non cash items
-102.87%-690K
----
----
----
----
1,215.70%24.05M
---5.31M
--0
-24,799.43%-86.2M
32,917.43%115.56M
Change In working capital
181.58%3.84M
128.76%176K
23.95%-1.15M
372.55%3.61M
194.77%1.2M
49.05%-4.71M
-820.00%-612K
58.59%-1.51M
68.15%-1.33M
17.07%-1.26M
-Change in receivables
--0
----
----
----
----
-126.64%-475K
-72.40%387K
35.41%-965K
-99.75%2K
-90.49%101K
-Change in inventory
----
----
----
----
----
--0
--0
--0
--0
--0
-Change in prepaid assets
9.86%-2.59M
-1,296.49%-4.77M
86.75%-236K
95.13%-70K
4,801.89%2.49M
-742.28%-2.87M
311.34%399K
-1,013.33%-1.78M
-391.87%-1.44M
84.27%-53K
-Change in payables and accrued expense
611.46%6.52M
1,047.64%5.01M
-389.70%-872K
2,603.68%3.68M
-10.15%-1.3M
88.91%-1.27M
59.37%-529K
112.42%301K
102.47%136K
47.65%-1.18M
-Change in other current liabilities
1.14%-87K
-800.00%-63K
-147.50%-38K
-72.00%7K
103.76%7K
-15.79%-88K
70.83%-7K
463.64%80K
247.06%25K
-1,330.77%-186K
-Change in other working capital
----
----
----
----
----
----
----
----
-206.25%-51K
618.18%158K
Cash from discontinued investing activities
Operating cash flow
-4.90%-51.46M
5.30%-14.25M
-41.97%-16.37M
30.05%-11.39M
-52.48%-9.46M
-59.90%-49.06M
-443.89%-15.04M
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
Investing cash flow
Cash flow from continuing investing activities
-23,055.06%-81.72M
2.4M
-13.26M
-70.86M
0
367.67%356K
0
0
0
367.67%356K
Net PPE purchase and sale
----
----
----
----
----
--0
--0
--0
--0
--0
Net business purchase and sale
--0
--0
--0
--0
--0
--356K
--0
--0
--0
--356K
Net investment purchase and sale
---81.72M
--2.4M
---13.26M
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
-23,055.06%-81.72M
--2.4M
---13.26M
---70.86M
--0
367.67%356K
--0
--0
--0
367.67%356K
Financing cash flow
Cash flow from continuing financing activities
-91.70%14.59M
-98.99%687K
14.37M
0.64%-469K
0
602.22%175.85M
6,770,800.00%67.71M
0
-178.93%-472K
690.02%108.61M
Net issuance payments of debt
----
----
----
----
--0
--0
--0
--0
--0
--0
Net common stock issuance
-87.23%14.76M
--392K
--14.37M
--0
--0
150.17%115.63M
--0
--0
--0
741.03%115.63M
Proceeds from stock option exercised by employees
-98.85%797K
-98.91%757K
--0
----
----
103,546.27%69.44M
--69.44M
--0
----
----
Net other financing activities
89.46%-972K
73.36%-462K
---1K
----
----
---9.22M
---1.73M
--0
---472K
---7.01M
Cash from discontinued financing activities
Financing cash flow
-91.70%14.59M
-98.99%687K
--14.37M
0.64%-469K
--0
602.22%175.85M
6,770,800.00%67.71M
--0
-178.93%-472K
690.02%108.61M
Net cash flow
Beginning cash position
1,684.76%134.7M
-66.76%27.26M
-54.55%42.52M
13.53%125.24M
1,685.00%134.7M
-43.33%7.55M
695.48%82.03M
1,349.82%93.56M
553.47%110.31M
-43.34%7.55M
Current changes in cash
-193.27%-118.59M
-121.19%-11.16M
-32.36%-15.26M
-393.70%-82.72M
-109.20%-9.46M
2,303.24%127.15M
2,004.70%52.67M
-398.70%-11.53M
-60.67%-16.76M
2,784.25%102.77M
End cash Position
-88.04%16.11M
-88.04%16.11M
-66.76%27.26M
-54.55%42.52M
13.53%125.24M
1,684.76%134.7M
1,684.76%134.7M
695.48%82.03M
1,349.82%93.56M
553.47%110.31M
Free cash flow
-4.90%-51.46M
5.30%-14.25M
-41.97%-16.37M
30.05%-11.39M
-52.48%-9.46M
-59.90%-49.06M
-443.89%-15.04M
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.90%-51.46M5.30%-14.25M-41.97%-16.37M30.05%-11.39M-52.48%-9.46M-59.90%-49.06M-443.89%-15.04M-68.62%-11.53M-47.68%-16.28M38.30%-6.2M
Net income from continuing operations -122.78%-78.26M61.18%-13.72M-232.94%-30.63M-121.09%-20.77M89.16%-13.15M-11.37%-35.13M-332.65%-35.34M540.65%23.04M1,301.79%98.46M-1,118.38%-121.29M
Operating gains losses 124.16%9.52M-122.31%-5.16M135.88%12.53M109.12%2.53M-416.67%-380K-5,572.92%-39.41M3,755.00%23.13M-34,825.00%-34.93M-69,425.00%-27.73M-33.33%120K
Depreciation and amortization 103.55%344K-76.47%16K73.53%59K306.06%134K297.06%135K6.96%169K58.14%68K-17.07%34K-19.51%33K3.03%34K
Deferred tax 44.74%165K14.91%131K171.43%10K7,400.00%525K-7,257.14%-501K714.29%114K1,366.67%114K-275.00%-14K0.00%7K-12.50%7K
Other non cash items -102.87%-690K----------------1,215.70%24.05M---5.31M--0-24,799.43%-86.2M32,917.43%115.56M
Change In working capital 181.58%3.84M128.76%176K23.95%-1.15M372.55%3.61M194.77%1.2M49.05%-4.71M-820.00%-612K58.59%-1.51M68.15%-1.33M17.07%-1.26M
-Change in receivables --0-----------------126.64%-475K-72.40%387K35.41%-965K-99.75%2K-90.49%101K
-Change in inventory ----------------------0--0--0--0--0
-Change in prepaid assets 9.86%-2.59M-1,296.49%-4.77M86.75%-236K95.13%-70K4,801.89%2.49M-742.28%-2.87M311.34%399K-1,013.33%-1.78M-391.87%-1.44M84.27%-53K
-Change in payables and accrued expense 611.46%6.52M1,047.64%5.01M-389.70%-872K2,603.68%3.68M-10.15%-1.3M88.91%-1.27M59.37%-529K112.42%301K102.47%136K47.65%-1.18M
-Change in other current liabilities 1.14%-87K-800.00%-63K-147.50%-38K-72.00%7K103.76%7K-15.79%-88K70.83%-7K463.64%80K247.06%25K-1,330.77%-186K
-Change in other working capital ---------------------------------206.25%-51K618.18%158K
Cash from discontinued investing activities
Operating cash flow -4.90%-51.46M5.30%-14.25M-41.97%-16.37M30.05%-11.39M-52.48%-9.46M-59.90%-49.06M-443.89%-15.04M-68.62%-11.53M-47.68%-16.28M38.30%-6.2M
Investing cash flow
Cash flow from continuing investing activities -23,055.06%-81.72M2.4M-13.26M-70.86M0367.67%356K000367.67%356K
Net PPE purchase and sale ----------------------0--0--0--0--0
Net business purchase and sale --0--0--0--0--0--356K--0--0--0--356K
Net investment purchase and sale ---81.72M--2.4M---13.26M----------0--0--0--------
Cash from discontinued investing activities
Investing cash flow -23,055.06%-81.72M--2.4M---13.26M---70.86M--0367.67%356K--0--0--0367.67%356K
Financing cash flow
Cash flow from continuing financing activities -91.70%14.59M-98.99%687K14.37M0.64%-469K0602.22%175.85M6,770,800.00%67.71M0-178.93%-472K690.02%108.61M
Net issuance payments of debt ------------------0--0--0--0--0--0
Net common stock issuance -87.23%14.76M--392K--14.37M--0--0150.17%115.63M--0--0--0741.03%115.63M
Proceeds from stock option exercised by employees -98.85%797K-98.91%757K--0--------103,546.27%69.44M--69.44M--0--------
Net other financing activities 89.46%-972K73.36%-462K---1K-----------9.22M---1.73M--0---472K---7.01M
Cash from discontinued financing activities
Financing cash flow -91.70%14.59M-98.99%687K--14.37M0.64%-469K--0602.22%175.85M6,770,800.00%67.71M--0-178.93%-472K690.02%108.61M
Net cash flow
Beginning cash position 1,684.76%134.7M-66.76%27.26M-54.55%42.52M13.53%125.24M1,685.00%134.7M-43.33%7.55M695.48%82.03M1,349.82%93.56M553.47%110.31M-43.34%7.55M
Current changes in cash -193.27%-118.59M-121.19%-11.16M-32.36%-15.26M-393.70%-82.72M-109.20%-9.46M2,303.24%127.15M2,004.70%52.67M-398.70%-11.53M-60.67%-16.76M2,784.25%102.77M
End cash Position -88.04%16.11M-88.04%16.11M-66.76%27.26M-54.55%42.52M13.53%125.24M1,684.76%134.7M1,684.76%134.7M695.48%82.03M1,349.82%93.56M553.47%110.31M
Free cash flow -4.90%-51.46M5.30%-14.25M-41.97%-16.37M30.05%-11.39M-52.48%-9.46M-59.90%-49.06M-443.89%-15.04M-68.62%-11.53M-47.68%-16.28M38.30%-6.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +6.33%
Sample Name
Sample Code
 +4.40%
Sample Name
Sample Code
 +3.43%
4
United States Gasoline Fund Lp
UGA
+0.46%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-1.17%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.08%
Sample Name
Sample Code
 +16.18%
Sample Name
Sample Code
 +15.82%
4
Baidu
BIDU
+15.52%
5
Zai Lab
ZLAB
+13.31%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -